Smith & Nephew (SNN)
Bid | 34.25 |
Market Cap | 15.66B |
Revenue (ttm) | 5.97B |
Net Income (ttm) | 493.64M |
EPS (ttm) | 1.12 |
PE Ratio (ttm) | 31.98 |
Forward PE | 16.1 |
Analyst | Hold |
Dividends | $1.04 |
Ask | 36.48 |
Volume | 956,269 |
Avg. Volume (20D) | 909,085 |
Open | 35.96 |
Previous Close | 36.10 |
Day's Range | 35.73 - 36.06 |
52-Week Range | 23.69 - 38.79 |
Beta | 0.67 |
Ex-Dividend Date | Oct 3, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for SNN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 month ago · proactiveinvestors.co.uk
Smith & Nephew: US bank upbeat after meetings with managementCiti has reiterated its buy rating on Smith & Nephew PLC (LSE:SN) following recent meetings with the company's CEO and CFO. The bank highlights a constructive tone around the business despite the deci...

1 month ago · proactiveinvestors.co.uk
US bank ‘buy' on Smith & Nephew after better-than-expected results and $500m buybackCiti has stuck with its ‘buy' call on Smith & Nephew PLC (LSE:SN) after the company delivered quarterly results that were, in Citi's words, “meaningfully better than expected”, and announced a $500mn ...

1 month ago · proactiveinvestors.co.uk
Smith+Nephew maintain guidance as it lifts profits and cash flow, launches $500 million buyback after strong first halfSmith & Nephew PLC (LSE:SN) maintained full-year guidance after reporting robust revenue growth and rising profitability on Tuesday, as the medical technology company posted strong sets of results for...